FUGAZZOLA, LAURA
FUGAZZOLA, LAURA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Will the autofluorescence take over inadvertent parathyroidectomy?Results from a multicentre cohort study
2025 D. Barbieri, P. Indelicato, S. DE LEO, C. Moneta, S. Coccia, G. Gazzano, L. Giordano, F. LIRA LUCE, D. Canta, L. Fugazzola, M. Bussi, G. Dionigi, M. Trevisan
Mitochondrial DNA and Ischemia Reperfusion Injury: Development of an Experimental Extra Corporeal Lung Perfusion (EVLP) Rat Model
2024 L. Rosso, I. Righi, C. Lonati, M. Battistin, M. Pinti, M. Cattaneo, V. Selleri, I. Campi, L. Fugazzola, M. Nosotti
Thyroid cancer and endocrine disruptive chemicals: a case–control study on per-fluoroalkyl substances and other persistent organic pollutants
2024 V. Cirello, M. Lugaresi, C. Moneta, P. Dufour, A. Manzo, E. Carbone, C. Colombo, L. Fugazzola, C. Charlier, C. Pirard
Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model
2024 V. Ghiandai, E.S. Grassi, G. Gazzano, L. Fugazzola, L. Persani
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex
2024 C. Colombo, D. Ceruti, M. Succi, S. De Leo, M. Trevisan, C. Moneta, L. Fugazzola
Extra-nuclear TERT counteracts oxidative stress and promotes progression in papillary thyroid carcinoma
2024 M. Muzza, G. Pogliaghi, C. Colombo, E.S. Grassi, E. Carbone, S. Palazzo, F. Frattini, G. Gazzano, L. Persani, L. Fugazzola
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting
2023 S. De Leo, M. Trevisan, C. Colombo, C. Moneta, N. Giancola, L. Fugazzola
Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer
2023 V. Cirello, C. Colombo, A. Manzo, D. Tosi, U. Gianelli, G. Gazzano, S. Ferrero, L. Persani, L. Fugazzola
Patient-Derived in vitro models for unraveling medullary thyroid cancer microenvironment and therapy resistance
2023 E.S. Grassi, V. Ghiandai, V. Cirello, G. Gazzano, G. Dionigi, L. Persani, L. Fugazzola
Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies
2023 A. Manzo, V. Cirello, E.S. Grassi, C. Colombo, L. Fugazzola, L. Persani
Characterization of epcam in thyroid cancer biology by three-dimensional spheroids in vitro model
2023 V. Ghiandai, E.S. Grassi, L. Fugazzola, L. Persani
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies
2023 A. Manzo, V. Cirello, E.S. Grassi, C. Colombo, L. Fugazzola, L. Persani
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
2023 C. Colombo, D. Ceruti, S. DE LEO, G. Bilo, M. Trevisan, N. Giancola, C. Moneta, G. Parati, L. Persani, L. Fugazzola
Effect of T3 on Lung Ischemia-Riperfusion Injury in an Evlp Rat Model: Results of Ad Interim Analyses
2023 I. Righi, L. Rosso, M. Cattaneo, C. Lonati, L. Vivona, M. Pinti, M. Battistin, A. Lombardi, V. Selleri, L. Fugazzola, I. Campi, M. Nosotti
Clinical outcomes of thermal ablation retreatment of benign thyroid nodules: A multicenter study from the Italian minimally-invasive treatments of the thyroid group
2023 S. Bernardi, V. Rosolen, F. Barbone, S. Borgato, M. Deandrea, P. De Feo, L. Fugazzola, G. Gambelunghe, R. Negro, S. Oleandri, G. Papi, E. Papini, F. Retta, R. Rossetto, D. Sansone, G. Serra, L.M. Sconfienza, L. Solbiati, S. Spiezia, F. Stacul, G. Mauri
Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer
2023 S. De Leo, M. Trevisan, G.V. Re Sartò, C. Moneta, M. Pirovano, C. Colombo, L. Cosmai, L. Fugazzola
Fetal cell microchimerism and susceptibility to COVID-19 disease in women
2023 V. Cirello, M. Lugaresi, A. Manzo, E. Balla, G. Fratianni, F. Solari, L. Persani, L. Fugazzola, I. Campi
Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
2022 D. Horgan, D. Führer-Sakel, P. Soares, C.V. Alvarez, L. Fugazzola, R.T. Netea-Maier, B. Jarzab, M. Kozaric, B. Bartes, J. Schuster-Bruce, L. DAL MASO, M. Schlumberger, F. Pacini
Neoplasie endocrine ereditarie
2022 P. Del Rio, L. Fugazzola, P.G. Calò
Three-dimensional spheroids: a new approach for the identification and characterization of novel markers for tumor-initiating cells subpopulations in thyroid cancer
2022 V. Ghiandai, E.S. Grassi, L. Fugazzola, L. Persani